Results 181 to 190 of about 83,920 (307)

The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challenges

Histopathology, EarlyView.
Invasive breast carcinomas with papillary features (IBCP) comprise diverse subtypes with variable architecture, histopathology, and clinical behaviour. This review outlines evolving classification, diagnostic criteria, and treatment implications, highlighting challenges in distinguishing in situ from invasive lesions. Standardised diagnostic approaches
Emad A Rakha, Puay Hoon Tan, Wendy A Raymond   +2 more
wiley   +1 more source

Prognostic significance of ductal carcinoma <i>in situ</i> coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes. [PDF]

Mol Clin Oncol
Fedai NK, Koc I, Kavgaci G, Uner M, Uner A, Aksoy S, Kertmen N.   +6 more
europepmc   +1 more source

Invasive Papillary Carcinomas of the Extrahepatic Bile Ducts: a Clinicopathologic and Immunohistochemical Study of 13 Cases [PDF]

, 2002
Mai P. Hoang, Linda A. Murakata, Nora Katabi, Donald E. Henson, Jorge Albores‐Saavedra   +4 more
openalex   +1 more source

Aquaporin‐1 differentiates intrahepatic cholangiocarcinoma from liver metastases of pancreatic ductal adenocarcinoma

Histopathology, EarlyView.
Differentiating intrahepatic CCA from PDAC metastatic to the liver is critical for the clinical management of patients with pancreatobiliary cancers. AQP1 has demonstrated an excellent discriminatory performance in this clinical scenario. Aims Differentiating intrahepatic cholangiocarcinoma (iCCA) from metastatic ductal adenocarcinoma of the pancreas ...
Leoncini Giuseppe, Barella Marco, Droz Dit Busset Michele, Gentili Marco, Bodini Beatrice, Ronchetti Simona, Cari Luigi, Mazzaferro Vincenzo   +7 more
wiley   +1 more source

mtDNA copy number/<i>miR663/AATF</i> axis in invasive ductal carcinoma of the breast. [PDF]

Bioimpacts
Dahi F, Shahbazi S, Geranpayeh L.
europepmc   +1 more source

Molecular Alterations in Osteosarcomas of the Oral and Maxillofacial Region: A Scoping Review

Journal of Oral Pathology &Medicine, EarlyView.
ABSTRACT Background Given the rarity and aggressive nature of osteosarcomas (OS) in the oral and maxillofacial region, understanding their molecular alterations is essential to improve diagnosis, prognosis, and guide targeted therapies. This study aimed to map molecular alterations associated with oral and maxillofacial OS, providing an overview of the
Iara Vieira Ferreira, Reydson Alcides de Lima‐Souza, Moisés Willian Aparecido Gonçalves, Carlos Takahiro Chone, Arthur Antolini‐Tavares, Albina Altemani, Fernanda Viviane Mariano   +6 more
wiley   +1 more source

Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma <i>In Situ</i> at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma. [PDF]

J Breast Cancer
Park B, Choi S, Han J, Jung SY, Lee S, Kang HS, Kim S, Kwon Y, Lee EG.   +8 more
europepmc   +1 more source

Prolonged exposure to artificial light and carcinogenesis: A systematic review of oncostatic mechanisms associated with melatonin pathways

Photochemistry and Photobiology, EarlyView.
Exposure to artificial light at night (ALAN), particularly at blue wavelengths, disrupts circadian rhythms by suppressing melatonin, thereby increasing cancer susceptibility. This systematic review consolidates evidence linking prolonged ALAN exposure to an elevated risk of breast and prostate tumors.
Gabriel Barboza, Jêmina Oliveira, Antônio Ferreira, Renan Lopes, Marli Cupertino   +4 more
wiley   +1 more source

Correlation between ultrasonic features and expression of immunohistochemical factors in invasive ductal carcinoma of the breast. [PDF]

Quant Imaging Med Surg
Yang Y, Cheng L.
europepmc   +1 more source

An Update on Early‐Onset Breast Cancer: Incidence, Risk Factors, Genetic Testing, and Treatment

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Early‐onset breast cancer presents in patients typically under the age of 40, while very early‐onset breast cancer is usually viewed as breast cancer occurring before the age of 35. Early‐onset breast cancer demonstrates specific molecular properties and has worse outcomes compared to its late‐onset breast cancer counterpart.
Leila Jahangiri
wiley   +1 more source